Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma

In metastatic renal cell carcinoma, complete response to first-line antiangiogenic agents is rare and resistance to therapy often develops. Protocols for sequential treatment with angiogenesis and mTOR inhibitors are under evaluation to improve outcomes. In this observational, real-world study, pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossetti, Sabrina, D'Aniello, Carmine, Iovane, Gelsomina, Scagliarini, Sarah, Laterza, Maria M., De Vita, Fernando, Savastano, Clementina, Cartenì, Giacomo, Porricelli, Maria A., Berretta, Massimiliano, Pisconti, Salvatore, Facchini, Gaetano, Cavaliere, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517440/
https://www.ncbi.nlm.nih.gov/pubmed/28775690
http://dx.doi.org/10.3389/fphar.2017.00484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517440/
https://www.ncbi.nlm.nih.gov/pubmed/28775690
http://dx.doi.org/10.3389/fphar.2017.00484

Ejemplares similares